Skip to main content

Day: September 8, 2023

Boralex and the Innu announce the closing of a financing for over $600 million for the Apuiat wind farm in Quebec

MONTRÉAL, Sept. 08, 2023 (GLOBE NEWSWIRE) — Boralex Inc. (“Boralex” or the “Company”) (TSX: BLX) and its Innu community partners in Parc éolien Apuiat S.E.C. (the “Innu”) are pleased to announce the closing of a $608 million financing for the Apuiat wind farm, located on Quebec’s North Shore. The long-term financing for the 200 MW Apuiat wind farm was secured by the Desjardins Group, acting as Coordinating Lead Arranger, Sole Bookrunner and Agent for the banking syndicate, which also included international financial institutions CaixaBank, DZ Bank AG and The Korea Development Bank. As financial advisor, Selkirk Advisory Group also contributed to the success of this financing. The financing for the Apuiat project comprises:A $465.3 million construction loan, to be converted to a term loan with a 25-year term after the start of...

Continue reading

TRX Gold to Present at the 25th Annual H.C. Wainwright Global Investment Conference and Precious Metals Summit Conference

TORONTO, Sept. 08, 2023 (GLOBE NEWSWIRE) — TRX Gold Corporation (TSX: TNX) (NYSE American: TRX) (the “Company” or “TRX Gold”) is pleased to announce that the Company’s executives have been invited to attend and present at H.C. Wainwright’s 25th Annual Global Investment Conference, taking place September 11th to 13th in New York City. The team will also be participating at the Precious Metals Summit in Beaver Creek, Colorado, taking place September 12th to 15th. Both events represent opportunities to network with important industry leaders, institutional investors, financial analysts and media. Please join us virtually for a live corporate update by registering through the following links: H.C. Wainwright 25th Annual Global Investment ConferenceManhattan, NYCSeptember 11, 12:00 PM – 12:30 PM ETWebcast Precious Metals SummitBeaver...

Continue reading

NeuBase Therapeutics Issues Statement Regarding Filing By Shareholder

PITTSBURGH, Sept. 08, 2023 (GLOBE NEWSWIRE) — NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”) today issued the following statement regarding the Schedule 13D filed with the U.S. Securities and Exchange Commission on August 31, 2023, by Symetryx Corporation (“Symetryx”) and their subsequent press release issued on September 6, 2023. “The NeuBase Board of Directors (“Board”) appreciates input from its shareholders. The Board remains committed to completing its comprehensive exploration of strategic alternatives focused on maximizing shareholder value. The Board does not believe that shareholder value will be enhanced by issuing the special $1 per share dividend Symetryx requested in their press release. The Board and management will continue to seek an open and active dialogue with its shareholders, including...

Continue reading

Plus Therapeutics Enters into License Agreement for Cerebrospinal Fluid Tumor Cell Enumeration Assay

CNSide™ assay is the gold standard diagnostic cerebrospinal fluid (CSF) assay for patients with suspected central nervous system (CNS) cancers As part of the agreement, Plus obtains a nonexclusive license and option for exclusivity for patients receiving CNS radiotherapy AUSTIN, Texas, Sept. 08, 2023 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today announced it has expanded its supply agreement with Biocept by acquiring an option to exclusively license Biocept’s CNSide, a CSF-based tumor cell capture and enumeration platform, for patients receiving CNS radiotherapy. The option ensures that Plus Therapeutics has ongoing expanded access to...

Continue reading

ProMIS Neurosciences Closes $20.4 Million Private Placement Financing

At-the-Market fundraise to support Company through several potentially value-creating milestones and beyond TORONTO, Ontario and CAMBRIDGE, Massachusetts, Sept. 08, 2023 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (Nasdaq: PMN) (“ProMIS” or the “Company”), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced that it closed its previously announced private investment in public equity (“PIPE”) financing, for the issuance and sale of common share units, each consisting of one of the Company’s common shares (the “Common Shares”) and one warrant to purchase one Common Share (the “Warrants”) (the “Common Share Units”)...

Continue reading

Altisource Announces Pricing of $17.5 Million Public Offering of Common Stock

LUXEMBOURG, Sept. 08, 2023 (GLOBE NEWSWIRE) — Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today announced the pricing of an underwritten public offering of 4,861,111 shares of its common stock at a price to the public of $3.60 per share. The gross proceeds of the offering to Altisource are expected to be approximately $17.5 million, before deducting the underwriting discounts and commissions and other estimated offering expenses. In addition, the Company granted the underwriters a thirty-day option to purchase up to an additional 729,166 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock in the offering are being sold by Altisource. B....

Continue reading

Hooker Furnishings Reports Second Quarter Sales and Earnings

MARTINSVILLE, Va., Sept. 08, 2023 (GLOBE NEWSWIRE) — Hooker Furnishings Corporation (NASDAQ-GS: HOFT), a global leader in the design, production, and marketing of home furnishings for nearly a century, today reported operating results for its fiscal 2024 second quarter and first half ended July 30, 2023. Fiscal 2024 Second Quarter overview:Consolidated net sales for the fiscal 2024 second quarter were $97.8 million, a decrease of $55.1 million, or 36% compared to the prior year second quarter, driven by industry-wide decreased demand for home furnishings, and the planned exits of unprofitable operations within the Home Meridian segment. Consolidated operating income for the quarter was $1.3 million or 1.3% of net sales, compared to $7.3 million, or 4.8% of net sales in the prior year period. Consolidated net income was $785,000...

Continue reading

Form 8.3 – [Form-8.3 EMIS GROUP PLC 07 09 2023] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree EMIS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Global Helicopter Swashplate Market Size to Reach USD 89.69 Billion in 2032 | Emergen Research

Rapid penetration of lightweight materials and rising demand for sensor technology and data analytics are major factors driving the helicopter swashplate market revenue growth Vancouver, Sept. 08, 2023 (GLOBE NEWSWIRE) — The global helicopter swashplate market size was USD 46.68 Billion in 2022 and is expected to register a revenue CAGR of 6.7% during the forecast period, according to the latest analysis by Emergen Research. Increasing focus on predictive maintenance is a major factor driving the market revenue growth. Integration of sensor technology and data analytics in swashplate systems enables real-time monitoring of its condition and performance. This trend facilitates predictive maintenance, allowing operators to identify potential issues or failures in advance and perform targeted maintenance or replacement. Health monitoring...

Continue reading

Insurance Industry Faces Average Annual Natural Catastrophe Losses of $133B, A New High According to Verisk Report

Exposure growth and inflation continue to drive increasing losses2023 Global Protection Gap MapThe gap between insured and total economic losses (the sum of insured and uninsured losses), by region, at the 1% exceedance probability (100-year return period) level.BOSTON, Sept. 08, 2023 (GLOBE NEWSWIRE) — The global modeled insured average annual loss from natural catastrophes is $133 billion, a new high captured in the latest analysis using Verisk’s extreme event solutions models. Not only should the insurance industry be prepared to experience total insured losses from natural catastrophes well in excess of $100 billion every year, but annual losses greater than $200 billion are also plausible. These values are up significantly over the decade, according to the 2023 Global Modeled Catastrophe Losses Report published...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.